Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis

Seminars in Dialysis

Volumn 20, Issue 1, 2007, Pages 1-4

  Goodman, William G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MS 27 5 C ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

BLOOD; BONE; CHRONIC KIDNEY FAILURE; HUMAN; METABOLISM; OSTEOLYSIS; PATHOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; SECONDARY HYPERPARATHYROIDISM;

BONE AND BONES; BONE RESORPTION; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; RENAL DIALYSIS;

EID: 33846446044     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00230.x     Document Type: Review

References (36)

1. Eknoyan G, Levin A, Levin NW: Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl. 3):1-201, 2003
2. Sherrard DJ, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV: The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43:436-442, 1993
3. Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WG: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258, 1994
4. Quarles LD, Lobaugh B, Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150, 1992
5. Cohen-Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere Ph, Gueris J, Bouillon R, Fournier A: Comparison of intact, midregion, and carboxyterminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516-524, 1991
6. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, De Bonis E, Darias E, Gonzales-Posada JM, et al.: Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47:1434-1442, 1995
7. 3, and radiology in end-stage renal disease. Kidney Int 44:1071-1077, 1993
8. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y: Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26:836-844, 1995
9. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622-631, 1995
10. Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH: Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460-1468, 2001
11. Martin KJ, Gonzalez EA: The evolution of assays for parathyroid hormone. Curr Opin Nephrol Hypertens 10:569-574, 2001
12. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P: Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 70:345-350, 2006
13. Souberbielle JC, Friedlander G, Cormier C: Practical considerations in PTH testing. Clin Chim Acta 366:81-89, 2006
14. Cantor T, Yang Z, Caraiani N, Ilamathi E: Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 52:1771-1776, 2006
15. Goodman WG: Recent developments in the management of secondary hyperparathyroidism. Kidney Int 59:1187-1201, 2001
16. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166, 1994
17. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
18. Pei Y, Hercz G, Greenwood C, Segre GV, Manuel A, Saiphoo C, Fenton S, Sherrard DJ: Risk factors for renal osteodystrophy: a multivariant analysis. J Bone Miner Res 10:149-156, 1995
19. Goodman WG, Jüppner H, Salusky IB, Sherrard DJ: Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 63:1-11, 2003
20. Goodman WG, Salusky IB, Jüppner H: New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments. Nephrol Dial Transplant 17:1731-1736, 2002
21. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G: Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953, 2006
22. United States Renal Data System: Annual Data Report. Minneapolis, MN: USRDS Coordinating Center, 2005
23. De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM: The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13:2762-2769, 2002
24. Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D: Renal osteodystrophy in diabetic patients. Kidney Int 44:159-164, 1993
25. Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC, Malluche HH: Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease. Kidney Int 64:737-742, 2003
26. Parfitt AM: Genetic effects on bone mass and turnover-relevance to black/white differences. J Am Coll Nutr 16:325-333, 1997
27. Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG: Changes in vertebral bone density in black and white girls during childhood and puberty. N Engl J Med 325:1597-1600, 1991
28. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung C, Kim LY, et al.: Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367, 1987
29. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, et al.: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809, 1998
30. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H: A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290, 1999
31. Gao P, Scheibel S, D'Amour P, John MR, Rao DS, Schmidt-Gayk H, et al.: Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614, 2001
32. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P: Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:3923-3929, 1996
33. Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, et al.: Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 46:697-703, 2000
34. Lehman G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG: Specific measurement of PTH(1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 68:1206-1214, 2005
35. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahradnik RJ, Gales B, et al.: Similar predictive value of bone turnover using first and second generation immunometric PTH assays in dialyzed children. Kidney Int 63:1801-1808, 2003
36. Cantor T: Parathyroid hormone assay drift: an unappreciated problem in dialysis patient management. Semin Dial 18:359-364, 2005